Progression-free survival as a predictor of overall survival in patients with advanced breast cancer: A real-world study from the China National Cancer Center and validation in the Memorial Sloan Kettering Cancer Center Cohort.

Hongnan Mo, Zijing Wang, Fei Ma et al.|Journal of Global Oncology|2019

Cited by 1